Thank you for taking the time to visit our website. Below is information about the new articles, fact sheets and guides that we have recently posted to HCV and HBV Advocate websites.
1. HCV Advocate Newsletter: October, 2013
In This Issue:
Drugs in Development: Genotype 2 and 3
Alan Franciscus, Editor-in-Chief—Often overlooked because of the frantic pace of HCV genotype 1 development, genotype 2 and 3 drugs are also advancing with a recent surge in drug development.
Lucinda K. Porter, RN—Lucinda analyzes different studies recently released including Non-Hodgkin Lymphomas, Sofosbuvir treatment in a more difficult patient population, metabolic disorders in people with HCV, and information about testing for HCV.
HEALTHWISE: Liver Diseases from A to W (Alagille to Wilson's)
Lucinda K. Porter, RN—Learn about all of the different liver disorders.
Disability & Benefits: Understanding Health Insurance Coverage Under the Affordable Care Act (ACA)
Jacques Chambers, CLU—On October 1, the roll out of the health insurance exchanges begins, and this article focuses on the different types and terms as well as other important information.
2. HBV Journal Review by Christine Kukka —In this month's column Chris reviews the following studies that will help you understand the complexities of hepatitis B:
Study Finds Only 21% of Hepatitis B Patients Are Treated Correctly
Combination of Chinese Herbs Plus Antiviral Entecavir Proves Effective
Caesarians Reduce Infection of Newborns When Mothers Have High Viral Loads
Combined Antiviral and Interferon Treatment Effective in Those Under Age 30
New Tenofovir Formula May Lead to Less Bone Loss and Kidney Problems
HBV Mutation Found Only in Men May Explain Their Higher Rates of Liver Damage
Sumo Wrestlers Found to Transmit HBV Infection
Taiwan's Hepatitis B Immunization of Infants Reduces Hepatitis B by 90%
Tenofovir Reverses Severe, Decompensated Cirrhosis
3. Andrew's Story
This is an awesome story of one man's struggle with multiple disorders and infections and how he conquered them.
4. A Guide to the Affordable Care Act (ACA)—By Jacques Chambers, CLU
We have complied Jacques articles on the ACA to help our readers better understand this confusing and complex new law. Click Here.
5. New & Updated Fact Sheets and Guides
Be sure to check out our new and recently updated Fact Sheets and Guides. Click Here.
6. Updated HCV Training Workshop Schedule!
7. Clinical Trials Postings: Updated—September 11, 2013!
Be sure to check out the latest clinical trial postings at the HCV Advocate News & Pipeline Blog. Just click on the links to the Drug Companies below the banner to see which drugs are in trials right now, where the trials are, and how to register for one.
Don’t forget that there is help as close as a phone call – the 877-HELP-4-HEP line (877-435-7443) is available 9:00am to 7:00pm Eastern Time. For more information about the services they offer either call or visit their Website at www.help4hep.org The helpline is run by The Support Partnership: a group of non-profits working together to help people affected by hepatitis C.
8. Top News (Blog) from the HCV Advocate News & Pipeline Blog includes:
Executive Director, Hepatitis C Support Project
Editor-in-Chief, HCV Advocate www.hcvadvocate.org
Editor-in-Chief, HBV Advocate www.hbvadvocate.org
**Questions and Comments: Questions and/or comments can be directed to email@example.com
**To receive the eblast in your email inbox simply send an e-mail to: firstname.lastname@example.org with nothing in the subject line and the following in the message body: subscribe emailalert. Make sure your email address is all lower case.